๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials in this register

19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris
NCT07186413Acne Vulgaris
Galderma R&D
Phase 3
561
Shanghai
2025-09-23
Recruiting
A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors
NCT06953453Cancer
Lee's Pharmaceutical Limited
Phase 1
100
Zhengzhou, Shanghai
2025-09-23
Recruiting
A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
NCT07136142Malignant Solid Tumor
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
150
Shanghai, Tianjin
2025-09-23
Recruiting
Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer
NCT07080216Cervical Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2
120
Hangzhou
2025-09-23
Recruiting
A Study of CC312 for Relapsed/Refractory Autoimmune Diseases
NCT07193810SLE - Systemic Lupus Erythematosus, IIM- Idiopathic Inflammatory Myopathies, SSc-Systemic Sclerosis
CytoCares Inc
Phase EARLY_PHASE1
6
Deyang
2025-09-23
Recruiting
Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovyยฎ) in Adult Obese or Overweight Subjects
NCT07150975Obesity/Overweight in Adult
Gan & Lee Pharmaceuticals.
Phase 3
420
Beijing
2025-09-23
Recruiting
A Prospective, Multi-Center Registry Study of Progressive Pulmonary Fibrosis (PPF) in China (PROFINA)
NCT07683728Progressive Pulmonary Fibrosis
Zuojun Xu
Observational
600
Beijing
2025-09-23
Recruiting
Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera
NCT07232290Polycythemia Vera (PV)
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 2
60
Tianjin
2025-09-23
Recruiting
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
NCT07141706Advanced/Metastatic Solid Tumors
DualityBio Inc.
Phase 1
253
Guangzhou, Harbin, Zhengzhou, Jinan
2025-09-23
Recruiting
Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid Tumors
NCT07186452Advanced Solid Tumors
Hansoh BioMedical R&D Company
Phase 1
18
Changsha
2025-09-23
Recruiting
Effects of Remimazolam and Ciprofol TIVA on PRAE in Pediatric Tonsillectomy and Adenoidectomy
NCT07118579Tonsillectomy With or Without Adenoidectomy
Tongji Hospital
Phase 4
114
Wuhan
2025-09-23
Recruiting
ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
NCT07038096Small Cell Lung Cancer, Neuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2
350
Guanzhou
2025-09-23
Recruiting
Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy
NCT07291154End Stage Renal Disease (ESRD), Maintenance Hemodialysis
Yunfeng Xia
Not applicable
392
Chongqing
2025-09-22
Recruiting
Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease
NCT07166757Parkinson Disease (PD)
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
Phase 1/2
90
Shanghai
2025-09-22
Recruiting
A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)
NCT07154264Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Dizal Pharmaceuticals
Phase 2
66
Hefei, Beijing, Guangzhou, Zhengzhou, Wuhan, Yichang, Changsha, Changzhou
2025-09-22
Not yet open
A Post-Market Study of Drug-Coated Peripheral Balloon Dilatation Catheter in Treating Femoropopliteal Artery Stenosis or Occlusive Lesions.
NCT07187128Femoropopliteal Artery Stenoses or Occlusive Lesions
BrosMed Medical Co., Ltd
Not applicable
150
Beijing, Chongqing
2025-09-22
Recruiting
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged โ‰ฅ40 to โ‰ค85 Years With Chronic Obstructive Pulmonary Disease.
NCT07053423Chronic Obstructive Pulmonary Disease
Sanofi
Phase 4
218
Chengdu, Guangzhou, Hangzhou, Xiamen
2025-09-22
Recruiting
VSV-02 Compassionate Use in Advanced Solid Tumors
NCT07260591Advanced Solid Tumor, Melanoma, Breast Cancer, Lung Cancer
The First Affiliated Hospital of Xinxiang Medical College
Phase 1
6
Xinxiang
2025-09-22
Recruiting
Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)
NCT07179783Prostate Cancer (Adenocarcinoma), Prostate Cancer Metastatic Castration-Resistant, Prostate Adenocarcinoma With Neuroendocrine Differentiation
Tianjin Medical University Second Hospital
Phase 2
28
Tianjin
2025-09-22
Not yet open
A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors
NCT07198321Cancer, PDAC, CRC (Colorectal Cancer), NSCLC
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2
450
Guangzhou
2025-09-22
Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
NCT07181109High Risk Cardiovascular Disease, Hypertension, High Cardiovascular Risk
Alnylam Pharmaceuticals
Phase 3
11,000
Beijing, Binhai, Changchun, Changsha, Chengdu, Chongqing, Dalian, Datong
2025-09-22
Recruiting
Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors
NCT07357623Pulmonary Neuroendocrine Tumor
Shanghai Chest Hospital
Phase 2
96
Hefei, Beijing, Zhengzhou, Shanghai
2025-09-22
Recruiting
A Study of YL242 in Subjects With Advanced Solid Tumors
NCT07197827Advanced Solid Tumor
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
424
Harbin, Shanghai, Hangzhou
2025-09-22
Recruiting
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
NCT07111520Non-small Cell Lung Cancer
BioNTech SE
Phase 1/2
880
Baoding, Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Hefei
2025-09-22
Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
NCT07116967Plaque Psoriasis
Bristol-Myers Squibb
Phase 3
3,040
Bengbu, Beijing, Chongqing, Fuzhou, Guangzhou, Shenzhen, Shijiazhuang, Harbin
2025-09-22
Recruiting
Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.
NCT07204522Febrile Neutropenia
Shanxi Bethune Hospital
Observational
20
Taiyuan
2025-09-22
Recruiting
A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma๏ผˆSELINA๏ผ‰
NCT07191431Lymphoma Cns
Ruijin Hospital
Not applicable
25
Shanghai
2025-09-22
Recruiting
Pre-emptive Endoscopic Vacuum Therapy Reduces the Incidence of Anastomotic Leakage After Colorectal Cancer Surgery
NCT07208786Colorectal Cancer, Colorectal Surgery, Complications, Anastomotic Leakage
Nanchong Central Hospital
Not applicable
110
Nanchong
2025-09-22
Recruiting
Population Pharmacokinetics of Remifentanil in Low-Weight Critically Ill Patients
NCT07301970Critical Illness, Pain
Fudan University
Observational
45
Shanghai
2025-09-22
Recruiting
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib
NCT07164170Non-Small Cell Lung Cancer
Abbisko Therapeutics Co, Ltd
Phase 2
86
Hefei, Beijing, Fuzhou, Guangzhou, Nanning, Harbin, Zhengzhou, Wuhan
2025-09-22
Recruiting
A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects
NCT07102251Healthy Subjects
Sunshine Lake Pharma Co., Ltd.
Phase 1
126
Hefei
2025-09-21
Recruiting
A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole
NCT07199504Restless Leg Syndrome Due to Uraemia
Yunfeng Xia
Phase 2/3
80
Chongqing
2025-09-20
Recruiting
Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma
NCT07162012NK/T-cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), DLBCL
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
24
Shanghai
2025-09-20
Not yet open
Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base
NCT07145931Head and Neck Cancer Squamous Cell Carcinoma, Skull Base--Cancer, Neoadjuvant Chemoimmunotherapy, Objective Response Rate
Sun Yat-sen University
Phase 2
24
Guangzhou
2025-09-20
Not yet open
Family-Supervised Prehabilitation to Reduce Postoperative Complications After Neoadjuvant Chemotherapy in Gastric Cancer
NCT07183358Stomach Neoplasms, Neoadjuvant Therapy
The Affiliated Hospital of Qingdao University
Not applicable
90
Qingdao
2025-09-20
Recruiting
To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer
NCT07195084Non-Small Cell Lung Cancer
Anhui Provincial Cancer Hospital
Not applicable
12
Hefei
2025-09-20
Recruiting
From Health Information to Health Decisions Integrating Mindfulness Into Digital Learning and Daily Life
NCT07157566Health Literacy, Food Literacy, Media Literacy, E-health Literacy
University of Macau
Not applicable
268
2025-09-20
Recruiting
Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
NCT07180212Bladder Cancer, Liquid Biopsy, Cystoscopy
Tianjin Medical University Second Hospital
Not applicable
360
Xingtai, Guangzhou, Haerbin, Kunming, Nanchang, Tianjin
2025-09-20
Not yet open
RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction
NCT07166380Transcranial Bone Marrow Injection, RK-4, Acute Large Hemispheric Infarction, Acute Ischemic Stroke
Neurodawn Pharmaceutical Co., Ltd.
Phase 1/2
18
Beijing
2025-09-20
Not yet open
Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies
NCT07186088Myopia
Ruihua Wei
Not applicable
30
Tianjin
2025-09-20
Recruiting
The Efficacy and Safety of Pregabalin Combined With Venlafaxine in Patients With Fibromyalgia
NCT07186751Fibromyalgia, Pregabalin, Venlafaxine, Pain
Beijing Tiantan Hospital
Not applicable
750
Beijin, Beijing
2025-09-20
Recruiting
Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia
NCT07182890Functional Dyspepsia, Probiotics, Depression, Anxiety
Xijing Hospital of Digestive Diseases
Phase 4
180
Xiโ€™an
2025-09-20
Not yet open
Analysis of Deoxyribonucleic Acid and Ribonucleic Acid Next-Generation Sequencing in Non-Small Cell Lung Cancer Patients Without Pathological Complete Response Following Neoadjuvant Immunotherapy
NCT07179445NSCLC
Tianjin Medical University Cancer Institute and Hospital
Observational
300
Tianjin
2025-09-20
Recruiting
Efficacy of Bacillus Coagulans in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia
NCT07187492Functional Dyspepsia, Probiotics, Depression, Anxiety
Xijing Hospital of Digestive Diseases
Phase 4
180
Xiโ€™an
2025-09-20
Recruiting
Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapy
NCT07160036Myopia
Ruihua Wei
Not applicable
180
Tianjin
2025-09-20
Recruiting
An Exploratory Clinical Study on the Safety and Efficacy of Autologous NK Cells in the Treatment of Pulmonary Nodules
NCT07185035Pulmonary Nodules, Solitary, Pulmonary Nodules, Multiple
The First Affiliated Hospital with Nanjing Medical University
Phase EARLY_PHASE1
24
Nanjing
2025-09-20
Recruiting
A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes
NCT07203599Androgenic Alopecia
Shenzhen People's Hospital
Phase 1/2
59
Shenzhen
2025-09-20
Recruiting
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
NCT07157787Primary Membranous Nephropathy
Alexion Pharmaceuticals, Inc.
Phase 2
30
Baotou, Beijing, Guangzhou, Shenzhen
2025-09-19
Active, closed
Orelabrutinib Plus Low-Dose Radiotherapy Or Rituximab For Ocular Adnexal MALT Lymphoma
NCT07247383Marginal Zone Lymphoma of Ocular Adnexal, Marginal Zone Lymphoma(MZL)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
39
Hangzhou
2025-09-19
Recruiting
A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer
NCT07114315Pancreatic Cancer
Akeso
Phase 2
160
Shanghai, Tianjin
2025-09-19
Not yet open
Involve-site Radiotherapy Combined With Chemotherapy and Immunotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
NCT07161115Rectal Adenocarcinoma
Longhao Li
Phase 2
60
Chongqing
2025-09-19
Recruiting
A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets
NCT07170800Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
WestVac Biopharma Co., Ltd.
Phase 2
60
Wuhan, Changsha, Nanjing, Jinan, Chengdu, Beijing, Shanghai
2025-09-19
Active, closed
Applying Interactive E-books on Breastfeeding to Enhance Nursing Students' Learning
NCT07071285Nursing Education Research, Nursing Students, Breastfeeding Education
China Medical University Hospital
Not applicable
100
2025-09-19
Recruiting
Perioperative Therapy for HER2-negative Hepatoid Adenocarcinoma of Stomach
NCT07178340Hepatoid Adenocarcinoma of Stomach
Peking University Cancer Hospital & Institute
Phase 2
30
Beijing
2025-09-18
Recruiting
Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases
NCT06848842Colorectal Liver Metastases
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
40
Beijing
2025-09-18
Recruiting
Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis
NCT07130604Plaque Psoriasis
InventisBio Co., Ltd
Phase 3
390
Beijing
2025-09-18
Recruiting
A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
NCT07126665Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2
116
Shanghai
2025-09-18
Active, closed
AI-Driven Accurate Diagnosis of Pathogens in Severe Pneumonia
NCT07461714Severe Pneumonia
Guangzhou Medical University
Observational
1,000
Guangzhou
2025-09-18
Not yet open
A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia
NCT07190261Autoimmune Hemolytic Anemia
Bing Han
Phase 2
3
Beijing
2025-09-18
Recruiting
A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2303 in Healthy Adult
NCT07199270Health Adult Subjects
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Phase 1
64
Beijing
2025-09-18
Recruiting
New-Generation GMA Laryngeal Mask Airway Versus Conventional Inflatable Laryngeal Mask Airway
NCT07177586Supraglottic Airway Devices Position
First Affiliated Hospital of Zhejiang University
Not applicable
1,384
Hangzhou
2025-09-18
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
NCT07190222Chronic Obstructive Pulmonary Disease
Sanofi
Phase 3
942
Baotou, Beijing, Changde, Changsha, Chengdu, Chongqing, Dalian, Foshan
2025-09-17
Recruiting
JS207 Combination Therapy in Triple-negative Breast Cancer
NCT07045311Triple-negative Breast Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
80
Hefei, Beijing, Guangzhou, Baoding, Harbin, Zhangzhou, Wuhan, Nanjing
2025-09-17
Recruiting
A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours
NCT06682780Advanced Solid Tumor
LaNova Medicines Limited
Phase 1/2
320
Shanghai
2025-09-17
Recruiting
Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & Bevacizumab
NCT07192185Hepatocellular Carcinoma (HCC)
Sun Yat-sen University
Phase 2
30
Guangzhou
2025-09-17
Recruiting
The Effect of Proton Pump Inhibitors(PPIs) on Endoscopic Treatment of Walled-off Necrosis (WON)
NCT07488299Pancreatic Walled-off Necrosis
Qilu Hospital of Shandong University
Not applicable
120
Jinan
2025-09-17
Recruiting
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07169578Alzheimers Disease
Hoffmann-La Roche
Phase 3
800
Xuzhou, Shanghai, Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou
2025-09-17
Recruiting
LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma
NCT07100067Relapsed/Refractory Multiple Myeloma(MM)
Nanjing Legend Biotech Co.
Not applicable
35
Beijing, Tianjin, Wuhan
2025-09-16
Recruiting
A Clinical Study of GK02 in Malignant Ascites
NCT07378436Malignant Ascites Caused by Advanced Solid Tumors
Beijing Geekgene Technology Co., LTD
Phase EARLY_PHASE1
9
Beijing
2025-09-16
Recruiting
Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)
NCT07215650Generalized Myasthenia Gravis
Candid Therapeutics
Phase 1
44
Fuzhou, Guangzhou, Guiyang, Zhengzhou, Changchun, Shanghai, Taiyuan, Chengdu
2025-09-16
Recruiting
Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
NCT07172204Intensive Chemotherapy Unfit, Newly Diagnosed Acute Myeloid Leukemia (AML), Age โ‰ฅ60
First Affiliated Hospital of Zhejiang University
Phase 2
25
Beijing, Shenzhen, Suzhou, Nanchang, Hangzhou
2025-09-16
Recruiting
Exploratory Clinical Study on the Safety of STR-P004
NCT07143617Autoimmune Diseases
Beijing GoBroad Hospital
Not applicable
39
Beijing
2025-09-16
Recruiting
Prenatal Cell-free DNA Screening in Pregnancies With Diverse Genetic Risk Profiles Utilizing Targeted and Whole-exome Sequencing
NCT07106853Genetic Disease
Women's Hospital School Of Medicine Zhejiang University
Observational
1,600
Hangzhou
2025-09-16
Recruiting
Phase I Study of HRS-6093 in Participants With Advanced Solid Tumors Harboring KRAS G12D Mutations
NCT07134998Advanced KRAS G12D Mutant Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1
153
Shanghai, Chengdu
2025-09-16
Recruiting
Sex Differences in NMDA-enhancing Treatment of Schizophrenia
NCT07122895Schizophrenia
China Medical University Hospital
Phase 2
90
2025-09-16
Recruiting
HD-tDCS for Adolescent Bipolar Depression Targeting S1
NCT07246044Adolescent, Bipolar Depression, tDCS, Primary Somatosensory Cortex
Jiangsu Province Nanjing Brain Hospital
Not applicable
100
Nanjing
2025-09-16
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
argenx
Phase 3
160
Fuzhou, Guangzhou, Beijing, Xi'an
2025-09-16
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
NCT07190209Chronic Obstructive Pulmonary Disease
Sanofi
Phase 3
942
Beijing, Changchun, Changsha, Chengdu, Foshan, Guangzhou, Hangzhou, Harbin
2025-09-16
Active, closed
Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers
NCT06990256Sleep Disorder, Aging
Huazhong University of Science and Technology
Not applicable
83
Wuhan
2025-09-16
Recruiting
Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery
NCT07163650Obesity, Weight Loss, Metabolic Surgery
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 4
60
Nanjing
2025-09-16
Recruiting
A Cohort Study on Increasing Blood Pressure Benefits in Sleep Apnea Patients After CPAP Treatment
NCT07357272Hypertension (HTN), Sleep Apnea Syndrome, Obstructive
Beijing Anzhen Hospital
Observational
200
Beijing
2025-09-15
Not yet open
Effect of Red and Blue Light Irradiation on Postoperative Wound Healing in Perianal Absces
NCT07155356Perianal Abscess
The Affiliated Hospital of Putian University
Not applicable
222
Putian
2025-09-15
By invitation
Intra-arterial Selective Hypothermic Magnesium Sulfate Infusion in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke
NCT07163299Acute Ischemic Stroke
Capital Medical University
Phase 1/2
42
Xuzhou
2025-09-15
Recruiting
Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an Anti-PD-L1 ADC) in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07115485Gastric or Gastroesophageal Junction Adenocarcinoma
Shanghai Henlius Biotech
Phase 2
60
Beijing
2025-09-15
Not yet open
Multicenter Validation Study on Autism Screening Using a Machine-assisted System
NCT07006948Autism Spectrum Disorder, Early Developmental Impairment, Language Development Disorders
Children's Hospital of Fudan University
Observational
1,000
Hefei, Xiamen, Liuzhou, Harbin, Kunshan, Xi'an, Shanghai, Chengdu
2025-09-15
Recruiting
Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis
NCT07088757Post-ERCP Pancreatitis
Changhai Hospital
Phase 4
1,366
Shanghai, Zhejiang
2025-09-15
Recruiting
Feasibility, Safety, and Preliminary Clinical Efficacy of Magnetic Resonance Imaging-guided Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression: A Randomized, Double-Blind, Controlled Pilot Study
NCT07185438Depression - Major Depressive Disorder
First Affiliated Hospital of Chongqing Medical University
Not applicable
45
Chongqing
2025-09-15
Recruiting
Prenatal Music Exposure to Enhance Postnatal Language Development
NCT07699536Pregnancy
Chinese University of Hong Kong
Not applicable
480
Shenzhen
2025-09-15
Recruiting
Exercise Rehabilitation for Cardiorenal Syndrome in HFrEF Patients
NCT07167368Cardiorenal Syndrome
Haiyan Pan
Not applicable
60
Nantong
2025-09-15
Recruiting
The Efficacy and Safety of Pregabalin Combined With Desvenlafaxine in Patients With Fibromyalgia
NCT07171320Fibromyalgia, Pregabalin, Pain
Beijing Tiantan Hospital
Not applicable
384
Beijing
2025-09-15
Not yet open
Risk-adapted Therapeutic Strategy in +1q NDMM
NCT07045168Multiple Myeloma
FengYan Jin
Observational
200
Changchun
2025-09-15
Recruiting
Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic Stroke
NCT07003386Acute Ischemic Stroke AIS
Shanghai Yueyang Integrated Medicine Hospital
Phase 2/3
66
Shanghai
2025-09-15
Recruiting
Effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on Memory and Cognitive Function in Adults With Sleep Deprivation: A Proof-of-Concept Study
NCT07084701Sleep Deprivation
Tao Liu
Not applicable
30
Tianjin
2025-09-15
Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
NCT07153471Osteoarthritis
Eli Lilly and Company
Phase 3
800
Baotou, Beijing, Chongqing, Harbin, Hefei, Jinan, Luoyang, Nanjing
2025-09-15
Recruiting
Hypofractionated Radiotherapy Combined With Immunochemotherapy for Conversion Treatment of Gastroesophageal Junction Adenocarcinoma
NCT07072351Gastroesophageal Junction Adenocarcinoma, Hypofractionated Radiotherapy, Immunotherapy, Chemotherapy
West China Hospital
Phase 1/2
88
Xiamen, Chengdu
2025-09-15
Not yet open
Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer
NCT07117877Platinum Resistant Ovarian Cancer, Platinum Refractory Epithelial Ovarian Cancer, Ovarian Cancer (OvCa)
Fudan University
Phase 2
33
Shanghai
2025-09-15
Not yet open
Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention
NCT07156591Gastric Retention
Fudan University
Observational
460
Shanghai
2025-09-15
Not yet open
Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors
NCT07182435Solid Tumor Malignancies
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Phase EARLY_PHASE1
36
Shenzhen
2025-09-15
Not yet open
Simple Surgical Glove Compression to Prevent Chemotherapy-Induced Peripheral Neuropathy
NCT07169864Breast Cancer, Chemotherapy Induced Peripheral Neuropathy (CIPN), Neoadjuvant Therapy
Jinsong Lu
Not applicable
44
Shanghai
2025-09-15
Not yet open
The Effect of Semaglutide on Bone Health
NCT07165158Osteoporosis, Osteoporosis Fracture, T2DM
The First Affiliated Hospital of Xiamen University
Phase 4
150
Xiamen
2025-09-15
Rows per page Showing 6001–6100 of 19052
Previous 59 60 61 62 63 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=61

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,786 of the 19,052 studies in this register are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3,920 have not yet opened recruitment, 2,668 are active but closed to new participants, and 678 are enrolling by invitation only. Eligibility for any study is decided by its study team.

→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.